Pressmeddelande

Publication of Biohit Oyj Renumeration Report 2021

Cision Publicerad: 10 May 2022 10:00

Biohit Oyj Renumeration Report May 10, at 11.00 am local time (EET)

Biohit Oyj’s Remuneration Report for the Governing Bodies is published today in PDF format. The Remuneration Report for the Governing Bodies is attached to this stock exchange release and also available at https://www.biohithealthcare.com/en/investors/.

Additional information:

CEO Päivi Siltala, Biohit Oyj
tel. +358 9 773 861
[email protected]
www.biohit.fi

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Bifogade filer

Release2021https://mb.cision.com/Main/18502/3563128/1576813.pdf

Biohit Oyj Renumeration Report 2021https://mb.cision.com/Public/18502/3563128/89a77baf6f63eb72.pdf

Nyheter om Biohit

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!